Pherecydes Pharma
Antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics.
Romainville, Francewww.pherecydes-pharma.com/en ↗
Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood17
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-03 | Grant | €2.0M | Bpifrance | View deal → |
Investors
1Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software